To assess U.S. geographic variation in the management of medication in elderly patients, the authors examined performance on two quality measures: the use of medications considered to be high-risk for the elderly and potentially harmful drug–disease interactions.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2010) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: